Adenosine activates mesangial cell proliferation

Cellular Signalling

Volumn 9, Issue 1, 1997, Pages 59-63

  MacLaughlin, Miriam ^a,b   Martinez Salgado, Carlos ^a   Eleno, Nelida ^a   Olivera, Ana ^a,c   Lopez Novoa, Jose M ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Adenosine; cAMP; Intracellular calcium; Mesangial cells; Proliferation

Indexed keywords

ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; THEOPHYLLINE; TRITIUM;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; TRITIUM;

EID: 0030941535     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0898-6568(96)00091-5     Document Type: Article

References (21)

1. Marangos P. J., Deckert J. and Bisserse J. C. (1987) Central Sites of Adenosine Action and Their Interaction with Various Drugs. In: Topics & Perspectives in Adenosine Research (Gerlach E. and Becker B.F., Eds), pp. 74-78. Springer-Verlag, Berlin.
2. Rubio R., Berne R. M. and Dobson J. G. (1973) Am. J. Physiol. 225, 938-953.
3. Berne R. M., Gidday J. M., Hill H. E., Curnish R. R. and Rubio R. (1987) Adenosine in the Local Regulation of Blood Flow; Some Controversies. In: Topics & Perspectives in Adenosine Research (Gerlach E. and Becker B.F., Eds), pp. 395-403. Springer-Verlag, Berlin.
4. Burnstock G. (1978) In: Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach (Bolis L. and Straub R.W. Eds.) Raven Press, New York, 365, pp. 107-118.
5. Sattin A. and Rall T. W. (1970) Mol. Pharmacol. 6, 13-23.
6. Ribeiro J. A. and Sebastiao A. M. (1986) Prog. Neurobiol. 26, 179-209.
7. Parsons W. J. and Stiles G. L. (1987) J. Biol. Chem. 262, 841-847.
8. Henrich M., Piper H. M. and Schrader J. (1987) Life Sci. 41, 2381-2388.
9. Stiles G. L., Pierson G., Sunay S. and Parsons W. J. (1986) Endocrinology 119, 1845-1851.
10. Huttemann E., Ukena D., Lenschow W. and Schawbe U. (1984) Naunyn Schmiedebergs Arch. Pharmak. 325, 226-233.
11. Daly, J. W. (1982) J. Med. Chem. 25, 197-207.
12. Freissmuth M., Hausleithner V., Tuisl E., Nanoff C. and Schultz W. (1987) Naunyn Schmiedebergs Arch. Pharmak. 335, 438-444.
13. López-Novoa J. M., Arriba G., Barrio V., and Rodriguez-Puyol D. (1987) Eur. J. Pharmacol. 134, 365-367.
14. Olivera A., Lamas S., Rodriguez-Puyol D. and López-Novoa J. M. (1989) Kidney Int. 35, 1300-1305.
15. Olivera A., Tomás M. and López-Novoa J. M. (1992) Am. J. Physiol. 262, C840-C844.
16. Olivera A., López-Rivas A. and López-Novoa J. M. (1992) Biochem. J. 282, 871-876.
17. Olivera A. and López-Novoa J. M. (1992) Br. J. Pharmacol. 107, 341-346.
18. Gillies R. J., Didier N. and Denton M. (1986) Anal Biochem 159, 109-113.
19. Simonson M. S., Wann S., Mené P., Dubyak G. R., Kester M., Nakazato Y., Sedor J. R. and Dunn M. J. (1989) J. Clin. Invest. 83, 708-712.
20. Montero A., Rodríguez-Barbero A. and López-Novoa J. M. (1993) Eur. J. Pharmacol. 243, 235-240.
21. Bruns R. F., Lu G. H. and Pugsley T. A. (1987) Adenosine receptor subtypes: Binding studies. In: Topics and Perspectives in Adenosine Research (Gerlach E. and Becker B. F., Eds) Springer-Verlag, Berlin, 59-73.